Learn more about the high-purity GMP-grade human activin A / INHBA protein, designed for therapeutic and research ...

As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...

Underscores high unmet need for a therapeutic alternative to opioids and surgical interventions –– Reflects positive preliminary Phase 2 Safety ...

Explaining America’s weirdly complicated food inspection system, including who regulates poultry and eggs and how Robert F. Kennedy Jr. is involved ...

C3i became the first contract development and manufacturing organization (CDMO) for cell and gene therapies in Canada to obtain a Drug Establishment License (DEL) to produce life-saving cell therapies ...

The "Mastering Pharmaceutical Document Management: Strategies for Compliance and Efficiency" training has been added to ResearchAndMarkets.com's offering. This specialized course offers a deep dive ...

The "Auditing and Qualifying Suppliers and Vendors Course - An Effective Risk Based Approach" training has been added to ResearchAndMarkets.com's offering. Supplier or vendor qualification is a ...

However, what some people do not realize is that compliance standards in the pharmaceutical industry go beyond maintaining patient safety to cover such important topics as data integrity, product ...

The Food and Drug Administration (FDA) approved Journavx (suzetrigine) on Jan. 30, a first-in-its-class medication that works by blocking pain signals in the peripheral nerves, before they reach the ...

STOCK PHOTO/Getty Images/iStockphoto A recall of chocolate-covered products has been elevated to the highest risk level by the U.S. Food and Drug Administration due to multiple undeclared allergens.

Designed to manufacture cell and gene therapies under the Food and Drug Administration's current good manufacturing practice (cGMP) standards, the facility will ensure that all treatment products ...